Previous close | 0.0240 |
Open | 0.0250 |
Bid | 0.0240 x 166154000 |
Ask | 0.0250 x 165000000 |
Day's range | 0.0240 - 0.0250 |
52-week range | 0.0180 - 0.0340 |
Volume | |
Avg. volume | 3,375,912 |
Market cap | 51.432M |
Beta (5Y monthly) | 0.22 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
MELBOURNE, Australia, November 18, 2022--Patrys Limited (ASX: PAB, "Patrys" or the "Company"), a therapeutic antibody development company, has announced the appointment of Dr. Charmaine Gittleson as the Chairman of the Board of Directors – a highly respected and experienced global biotechnology leader.